On November 5, Philip Morris fell 3.18% in Regular Trading, trading at $207.77 per share with turnover of $150 million.
The move coincided with a fresh analyst view that heavy investment behind ZYN is likely to pressure near-term US profitability. The note said fourth-quarter selling, general and administrative expense could rise about 10% sequentially, implying US operating companies income may be around break-even to slightly negative.
That caution came shortly after Philip Morris reported quarterly adjusted EPS of $2.36 on revenue of $11.44 billion, both above consensus expectations. However, the market focus appears to have shifted toward the profit trade-off from sustained US investment in nicotine pouches, which the analyst expects to continue into the following year even as combustibles and international smoke-free products support the company’s medium-term targets.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments